FAV-201 Uses, Dosage, Side Effects and more

FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.

FAV-201 is a recombinant, patient-specific, T-cell receptor-based immunotherapy designed to induce an active immune response against the unique protein found on the surface of T-cells that constitute a patient's lymphoma.

Trade Name FAV-201
Generic FAV-201
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in lymphoma (non-hodgkin's).

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share